Hyaluronan - Magic glue for the regulation of the immune response?

Trends in Immunology

Volumn 24, Issue 3, 2003, Pages 112-114

  Termeer, Christian ^a   Sleeman, Jonathan P ^b   Simon, Jan C ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; HYALURONIDASE; OLIGOSACCHARIDE;

ANTIGEN PRESENTING CELL; AUTOCRINE EFFECT; BIOSYNTHESIS; DENDRITIC CELL; ENZYME DEGRADATION; EXTRACELLULAR MATRIX; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; LUNG INJURY; MACROPHAGE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; REGULATORY MECHANISM; SHORT SURVEY; SURFACE PROPERTY;

EID: 0037373616     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(03)00029-2     Document Type: Short Survey

References (21)

1. Johnson G.B., et al. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J. Immunol. 168:2002;5233-5239.
2. Termeer C., et al. Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J. Exp. Med. 195:2002;99-111.
3. Yang R., et al. Hyaluronic acid and chondroitin sulphate A rapidly promote differentiation of immature DC with upregulation of costimulatory and antigen-presenting molecules and enhancement of NF-κB and protein kinase activity. Scand. J. Immunol. 55:2002;2-13.
4. McKee C.M., et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J. Clin. Invest. 98:1996;2403-2413.
5. Lesley J., et al. Hyaluronan binding by cell-surface CD44. J. Biol. Chem. 275:2000;26967-26975.
6. Mummert M.E., et al. Synthesis and surface expression of hyaluronan by dendritic cells and its potential role in antigen presentation. J. Immunol. 169:2002;4322-4331.
7. Morrison H., et al. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev. 15:2001;968-980.
8. Yang T., et al. Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas. Cancer Res. 62:2002;2583-2591.
9. Hiltunen E.L., et al. Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors. Cancer Res. 62:2002;6410-6413.
10. McKee C.M., et al. Hyaluronan fragments induce nitric oxide synthase in murine macrophages through a nuclear factor-κB-dependent mechanism. J. Biol. Chem. 272:1997;8013-8018.
11. Teder P., et al. Resolution of lung inflammation by CD44. Science. 296:2002;155-158.
12. Sampson P.M., et al. Cytokine regulation of human lung fibroblast hyaluronan production. Evidence for cytokine-regulated hyaluronan degradation and human lung fibroblast-derived hyaluronidase. J. Clin. Invest. 90:1992;1492-1503.
13. Camenisch T.D., McDonald J.A. Hyaluronan: is bigger better? Am. J. Respir. Cell Mol. Biol. 23:2000;431-433.
14. O'Neill L.A. Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal? Trends Immunol. 23:2002;296-300.
15. Biragyn A., et al. Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science. 298:2002;1025-1029.
16. Banerji S., et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell. Biol. 144:1999;789-801.
17. Bono P., et al. Layilin, a novel integral membrane protein, is a hyaluronan receptor. Mol. Biol. Cell. 12:2001;891-900.
18. Wang J.Y., Roehrl M.H. Glycosaminoglycans are a potential cause of rheumatoid arthritis. Proc. Natl. Acad. Sci. U. S. A. 99:2002;14362-14367.
19. Lokeshwar V.B., et al. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. J. Biol. Chem. 276:2001;11922-11932.
20. Girard N., et al. Human monocytes synthesize hyaluronidase. Br. J. Haematol. 119:2002;199-203.
21. Patel S., et al. Hyaluronidase gene profiling and role of hyal-1 overexpression in an orthotopic model of prostate cancer. Int. J. Cancer. 97:2002;416-424.